Barry Labinger has an estimated net worth of $6.92 Million. This is based on reported shares across multiple companies, which include Emergent BioSolutions Inc., Checkmate Pharmaceuticals, Inc., HUMAN GENOME SCIENCES INC, and ANADYS PHARMACEUTICALS INC.

2011 was Barry Labinger's most active year for acquiring shares with 9 total transactions. Barry Labinger's most active month to acquire stocks was the month of February. 2012 was Barry Labinger's most active year for disposing of shares, totalling 10 transactions. Barry Labinger's most active month to dispose stocks was the month of June. 2014 saw Barry Labinger paying a total of $394,945.40 for 42,179 shares, this is the most they've acquired in one year. In 2012 Barry Labinger cashed out on 791,171 shares for a total of $10,825,596.75, their largest year based on trade value.